This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Sysmex Corporation. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Munehisa Izuka: Innovator in Blood Analysis Technology
Introduction
Munehisa Izuka is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of blood analysis, holding a total of 2 patents. His innovative work focuses on methods and devices that enhance the detection of blood-related conditions.
Latest Patents
Izuka's latest patents include a blood analyzing method and a blood analyzer. The blood analyzing method involves irradiating light on a measurement sample prepared with fluorescent dye. This process produces a difference in fluorescence intensity between reticulocytes and mature red blood cells in a blood sample. The method detects scattered light and fluorescent light emitted from blood cells, allowing for the determination of the presence of parasites based on the distribution of blood cells. The blood analyzer comprises a sample preparing part, a detecting part, an output part, and an analyzing part. It identifies populations of red blood cells infected by the ring-form malaria parasite, providing crucial information regarding infections.
Career Highlights
Munehisa Izuka is associated with Sysmex Corporation, a company known for its advancements in medical diagnostics. His work has significantly impacted the efficiency and accuracy of blood analysis, contributing to better healthcare outcomes.
Collaborations
Izuka has collaborated with notable coworkers, including Takuma Watanabe and Yuhgi Suzuki. Their combined efforts have furthered the development of innovative blood analysis technologies.
Conclusion
Munehisa Izuka's contributions to blood analysis technology exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
